HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Spain’s Biosearch Looks To Probiotics For COVID-19

Executive Summary

Biosearch Life is investigating whether its patented l. coryniformis CECT5711 K8 strain of probiotics could be effective in reducing the incidence and/or severity of COVID-19 infection.

You may also be interested in...



Studies To Investigate If Betadine Mouthwash Can Prevent COVID-19 Infection

Clincal studies planned to test if povidone-iodine, marketed widely as consumer health products under the brand name Betadine, can prevent infection with the novel coronavirus.

France Warns Supplements Can Interfere With Immune Response To COVID-19

Dietary supplements containing certain plants can inhibit the immune response to COVID-19 and should not be taken by those showing symptoms of the virus, according to French regulator ANSES.

UK’s Clinova Investigates OTC Hydration Tablets For COVID-19

UK's Clinova is launching a study to determine if its ORS re-hydration product can help speed up recovery time for COVID-19 sufferers. 

Topics

UsernamePublicRestriction

Register

LL1122113

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel